Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

An emerging strategy of gene therapy for cardiac disease.

Yoshida Y, Yamanaka S.

Circ Res. 2012 Oct 12;111(9):1108-10. doi: 10.1161/CIRCRESAHA.112.278820. No abstract available.

2.

Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5.

Inagawa K, Miyamoto K, Yamakawa H, Muraoka N, Sadahiro T, Umei T, Wada R, Katsumata Y, Kaneda R, Nakade K, Kurihara C, Obata Y, Miyake K, Fukuda K, Ieda M.

Circ Res. 2012 Oct 12;111(9):1147-56. doi: 10.1161/CIRCRESAHA.112.271148. Epub 2012 Aug 28.

3.

"Triplet" polycistronic vectors encoding Gata4, Mef2c, and Tbx5 enhances postinfarct ventricular functional improvement compared with singlet vectors.

Mathison M, Singh VP, Gersch RP, Ramirez MO, Cooney A, Kaminsky SM, Chiuchiolo MJ, Nasser A, Yang J, Crystal RG, Rosengart TK.

J Thorac Cardiovasc Surg. 2014 Oct;148(4):1656-1664.e2. doi: 10.1016/j.jtcvs.2014.03.033. Epub 2014 Mar 27.

PMID:
24755332
4.

A reliable recipe for heart cells?

Williams R.

Circ Res. 2010 Oct 29;107(9):1042-3. doi: 10.1161/RES.0b013e3181ffeac0.

5.

Converting scar to muscle in the injured heart.

Riley PR.

Mol Ther. 2012 Jul;20(7):1294-6. doi: 10.1038/mt.2012.121. No abstract available.

6.

Turning cardiac fibroblasts into cardiomyocytes in vivo.

Xu C.

Trends Mol Med. 2012 Oct;18(10):575-6. doi: 10.1016/j.molmed.2012.06.009. Epub 2012 Jul 5.

PMID:
22770847
7.

Ethanol and its metabolites induce histone lysine 9 acetylation and an alteration of the expression of heart development-related genes in cardiac progenitor cells.

Zhong L, Zhu J, Lv T, Chen G, Sun H, Yang X, Huang X, Tian J.

Cardiovasc Toxicol. 2010 Dec;10(4):268-74. doi: 10.1007/s12012-010-9081-z.

PMID:
20811785
8.

Gata4, Tbx5 and Baf60c induce differentiation of adipose tissue-derived mesenchymal stem cells into beating cardiomyocytes.

Li Q, Guo ZK, Chang YQ, Yu X, Li CX, Li H.

Int J Biochem Cell Biol. 2015 Sep;66:30-6. doi: 10.1016/j.biocel.2015.06.008. Epub 2015 Jun 10.

PMID:
26071180
9.

In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes.

Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, Liu L, Conway SJ, Fu JD, Srivastava D.

Nature. 2012 May 31;485(7400):593-8. doi: 10.1038/nature11044.

10.

A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells.

Protze S, Khattak S, Poulet C, Lindemann D, Tanaka EM, Ravens U.

J Mol Cell Cardiol. 2012 Sep;53(3):323-32. doi: 10.1016/j.yjmcc.2012.04.010. Epub 2012 Apr 28.

PMID:
22575762
11.

Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5.

Chen JX, Krane M, Deutsch MA, Wang L, Rav-Acha M, Gregoire S, Engels MC, Rajarajan K, Karra R, Abel ED, Wu JC, Milan D, Wu SM.

Circ Res. 2012 Jun 22;111(1):50-5. doi: 10.1161/CIRCRESAHA.112.270264. Epub 2012 May 10.

12.

Effect of cell-based intercellular delivery of transcription factor GATA4 on ischemic cardiomyopathy.

Bian J, Popovic ZB, Benejam C, Kiedrowski M, Rodriguez LL, Penn MS.

Circ Res. 2007 Jun 8;100(11):1626-33. Epub 2007 May 10.

13.

Cell-based GATA4 cardiac gene transfer using cell-penetrating peptide.

Tang T, Hammond HK.

Circ Res. 2007 Jun 8;100(11):1540-2. No abstract available.

14.

Microarray analysis of global changes in gene expression during cardiac myocyte differentiation.

Peng CF, Wei Y, Levsky JM, McDonald TV, Childs G, Kitsis RN.

Physiol Genomics. 2002;9(3):145-55. Epub 2002 Apr 16.

PMID:
12045295
15.

Inhibition of Gata4 and Tbx5 by Nicotine-Mediated DNA Methylation in Myocardial Differentiation.

Jiang XY, Feng YL, Ye LT, Li XH, Feng J, Zhang MZ, Shelat HS, Wassler M, Li Y, Geng YJ, Yu XY.

Stem Cell Reports. 2017 Feb 14;8(2):290-304. doi: 10.1016/j.stemcr.2016.12.016. Epub 2017 Jan 19.

16.

New insights into the open artery hypothesis.

Kloner RA, Hwang H.

Circ Res. 2008 Jul 3;103(1):1-3. doi: 10.1161/CIRCRESAHA.108.180216. No abstract available.

17.

Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming.

Wang L, Liu Z, Yin C, Asfour H, Chen O, Li Y, Bursac N, Liu J, Qian L.

Circ Res. 2015 Jan 16;116(2):237-44. doi: 10.1161/CIRCRESAHA.116.305547. Epub 2014 Nov 21.

18.

Myogenic differentiation in atrium-derived adult cardiac pluripotent cells and the transcriptional regulation of GATA4 and myogenin on ANP promoter.

Kamrul Hasan M, Komoike Y, Tsunesumi S, Nakao R, Nagao H, Matsuoka R, Kawaguchi N.

Genes Cells. 2010 May;15(5):439-54. doi: 10.1111/j.1365-2443.2010.01394.x. Epub 2010 Apr 7.

19.

Labor pains of new technology: direct cardiac reprogramming.

Yoshida Y, Yamanaka S.

Circ Res. 2012 Jun 22;111(1):3-4. doi: 10.1161/CIRCRESAHA.112.271445. No abstract available.

20.

Transcriptional analysis of the human cardiac calsequestrin gene in cardiac and skeletal myocytes.

Reyes-Juárez JL, Juárez-Rubí R, Rodríguez G, Zarain-Herzberg A.

J Biol Chem. 2007 Dec 7;282(49):35554-63. Epub 2007 Oct 15.

Supplemental Content

Support Center